Browse > Article
http://dx.doi.org/10.4070/kcj.2011.41.4.177

Association Between Plaque Thickness of the Thoracic Aorta and Recurrence of Atrial Fibrillation After Ablation  

Hwang, Hui-Jeong (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Lee, Man-Young (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Youn, Ho-Joong (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Oh, Yong-Seog (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Rho, Tae-Ho (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Chung, Wook-Sung (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Park, Chul-Soo (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Choi, Yun-Seok (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Chung, Woo-Baek (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Lee, Jae-Beom (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Park, Hyun-Keun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Lim, Keun-Joon (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Lee, Jae-Hak (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Publication Information
Korean Circulation Journal / v.41, no.4, 2011 , pp. 177-183 More about this Journal
Abstract
Background and Objectives: Several predictors of recurrence of atrial fibrillation (AF) after ablation have been identified, including age, type of AF, hypertension, left atrial diameter and impaired left ventricular ejection fraction. The aim of this study was to investigate whether the atherosclerotic plaque thickness of the thoracic aorta is associated with a recurrence of AF after circumferential pulmonary vein ablation (CPVA). Subjects and Methods: Among patients with drug-refractory paroxysmal or persistent AF, 105 consecutive (mean age 58${\pm}$11 years, male : female=76 : 29) patients who underwent transesophageal echocardiography and CPVA were studied. The relationships between the recurrence of AF and variables, including clinical characteristics, plaque thickness of the thoracic aorta, laboratory findings and echocardiographic parameters were evaluated. Results: A univariate analysis showed that the presence of diabetes {hazard ratio (HR)=3.425; 95% confidence interval (CI), 1.422-8.249, p=0.006}, ischemic heart disease (HR=4.549; 95% CI, 1.679-12.322, p=0.003), duration of AF (HR=1.010; 95% CI, 1.001-1.018, p=0.025), type of AF (HR=2.412, 95% CI=1.042-5.584, p=0.040) and aortic plaque thickness with ${\geq}$4 mm (HR=9.514; 95% CI, 3.419-26.105, p<0.001) were significantly associated with the recurrence of AF after ablation. In Cox multivariate regression analysis, only the aortic plaque thickness (with ${\geq}$4 mm) was an independent predictor of recurrence of AF after ablation (HR=7.250, 95% CI=1.906-27.580, p=0.004). Conclusion: Significantly increased aortic plaque thickness can be a predictable marker of recurrence of AF after CPVA.
Keywords
Atrial fibrillation; Catheter ablation; Atherosclerosis; Aorta, thoracic;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22: 983-8.   DOI   ScienceOn
2 Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.   DOI   ScienceOn
3 Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibr-illation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5.   DOI   ScienceOn
4 Lee KS, Choi SJ, Park SH, Kim HL, Min H, Park HY. Prevalence of atrial fibrillation in middle-aged people in Korea: the Korean genome and epidemiology study. Korean Circ J 2008;38:601-5.   DOI   ScienceOn
5 Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Mar-chlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006;3:1024-8.   DOI   ScienceOn
6 Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Pre-valence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155:469-73.   DOI   ScienceOn
7 Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994;271: 840-4.   DOI   ScienceOn
8 Berruezo A, Tamborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007;28:836-41.   DOI   ScienceOn
9 Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and He-alth Study. Am J Med 2005;118:489-95.   DOI   ScienceOn
10 Goto S, Bhatt DL, Rother J, et al. Prevalence, clinical profile, and car-diovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855-63.   DOI   ScienceOn
11 Heeringa J, van der Kuip DA, Hofman A, et al. Subclinical atherosclerosis and risk of atrial fibrillation. Arch Intern Med 2007;167: 382-7.   DOI   ScienceOn
12 Blackshear JL, Pearce LA, Hart RG, et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke 1999;30:834-40.   DOI   ScienceOn
13 Agmon Y, Khandheria BK, Meissner I, et al. Association of atrial fibrillation and aortic atherosclerosis: a population-based study. Mayo Clin Proc 2001;76:252-9.   DOI   ScienceOn
14 De Potter T, Berruezo A, Mont L, et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation abl-ation. Europace 2010;12:24-9.   DOI   ScienceOn
15 Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace 2010;12:30-6.   DOI   ScienceOn
16 Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the me-thods, efficacy, and safety of catheter ablation for human atrial fibrill-ation. Circulation 2005;111:1100-5.   DOI   ScienceOn
17 Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systo-lic function. J Am Coll Cardiol 2004;43:1004-9.   DOI   ScienceOn
18 Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guide lines for the management of patients with atrial fibrillation. Circulation 2006;114:e257-354.   DOI   ScienceOn
19 Natale A, Raviele A, Arentz T, et al. Venice chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007;18:560-80.   DOI   ScienceOn
20 Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrill-ation: standards for acquisition and interpretation and assessment of interobserver variability. J Am Soc Echocardiogr 1996;9:556-66.
21 Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331: 1474-9.   DOI   ScienceOn
22 Otto CM. Textbook of Clinical Echocardiography. 4th ed. Philadelphia: W.B. Saunders Company;2009. p.125-56.
23 Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008;51:1-11.   DOI   ScienceOn
24 Hwang GS, Kim YH, Kim MK, et al. Gene expression and ultrast-ructural remodeling in persistent atrial fibrillation. Korean Circ J 2004;34:693-705.   DOI
25 Park JH, Oh YS, Kim JH, et al. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on patients follow-ing ablation of atrial fibrillation. Korean Circ J 2009;39:185-9.   DOI   ScienceOn
26 Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantific-ation of left arterial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circul-ation 2009;119:1758-67.   DOI   ScienceOn
27 Boisvert WA, Rose DM, Boullier RA, et al. Leukocyte transglutami-nase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 2006;26:563-9.
28 Mackey RH, Venkitachalam L, Sutton-Tyrrell K. Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007;44:234-44.
29 Cheema A, Vasamreddy CR, Dalal D, et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2006;15:145-55.   DOI   ScienceOn
30 Hof I, Arbab-Zadeh A, Scherr D, et al. Correlation of left atrial diame-ter by echocardiography and left atrial volume by computed tomography. J Cardiovasc Electrophysiol 2009;20:159-63.   DOI   ScienceOn